The recommendation is included in the organization’s “Guidelines for the management of chronic coronary syndromes,” published Aug. 30 in the European Heart Journal.
“Ultrasound contrast agents considerably enhance the quality of diagnostic images obtained during stress echocardiography,” the guidelines said, adding the use of a contrast agent “markedly” improves echocardiography accuracy.
The recommendation is supported by the European Association of Cardiovascular Imaging and the American Society of Echocardiography, according to the European Society of Cardiology.
Read more about the recently published guidelines from the European Society of Cardiology for elevated blood pressure and hypertension, atrial fibrillation, peripheral arterial and aortic diseases and other chronic coronary syndromes here.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
